NASDAQ:CNCR   Loncar Cancer Immunotherapy ETF
This is CNCR Loncar Cancer Immunotherapy ETF , it is trading +25% year to date, some of its 30 holdings are ATRA , IOVA , NKTR , JNCE , BGNE , ACEN, 64% in Micro Cap, last price $30.60, expense ratio 0.79%. We are bullish on it and you could too.


The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.